This Week in Nature

In this week's Nature Biotechnology, a team from Massachusetts General Hospital reports on the development of a next-generation CRISPR-based gene-editing platform. Monomeric Cas9 nucleases are commonly used to induce the genomic alterations in CRISPR systems, but the researchers note that these often result in unwanted off-target mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Be Gone

This Week in Cell

This Week in Nature

This Week in PLOS

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.